Sign in
SCHEDULE 13G/A

Statement of Beneficial Ownership

AgomAb Therapeutics NV Filed Acc 0000905148-26-004929

Stakes reported in this filing

Reporting person Shares Of the class
Redmile Group, LLC 1,740,230 3.5%
Jeremy C. Green 1,740,230 3.5%
Redmile Biopharma Investments III, L.P. 1,740,230 3.5%

Members of a group can each report the same shares, so these rows overlap and don't add up.

Loading xslSCHEDULE_13G_X02/primary_doc.xml…